UBS analyst Kevin Caliendo raised the firm’s price target on Labcorp (LH) to $305 from $282 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH:
- Labcorp price target raised to $310 from $290 at Truist
- Labcorp price target raised to $302 from $290 at Baird
- Labcorp price target raised to $306 from $283 at Morgan Stanley
- Positive Outlook for Labcorp Holdings: Buy Rating Justified by Strong Future Prospects and Strategic Growth Initiatives
- Labcorp Reports Strong Q2 2025 Results, Raises Guidance